{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:03:04Z","timestamp":1779181384688,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Heidelberg der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Intermediate age-related macular degeneration (iAMD) reduces vision under low-luminance conditions, affecting quality of life (QoL). The Vision Impairment in Low Luminance (VILL) questionnaire captures QoL domains relevant in iAMD but most AMD studies use the generic vision-related QoL measure Visual Function Questionnaire (NEI VFQ). To investigate associations between these generic and specific vision-related QoL instruments, and explore the added value of including the VILL over the NEI VFQ in future iAMD studies, we analysed cross-sectional study data from individuals with iAMD. Associations were investigated using age-adjusted regression models. We included 150 participants (73% women, 74.6\u2009\u00b1\u20097.8 years). VILL subscale scores were associated with NEI VFQ scores (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.014) and explained 62.0% to 67.9% in the variance of the NEI VFQ scores. Ceiling effects were more common in the visual functioning NEI VFQ subscale than in the VILL-Reading subscale (<jats:italic>p<\/jats:italic>\u2009=\u20090.039), while the emotional well-being scores did not differ signficiantly between the instruments. NEI VFQ scores, VILL-Reading and VILL-Mobility subscale scores were associated with best-corrected visual acuity in either eye. Thus, assessments of vision-related QoL in iAMD using a generic instrument and a low luminance vision-specific instrument yield comparable but not identical results. The VILL has less ceiling effects than the NEI VFQ, suggesting its suitability for iAMD intervention trials and added value over the NEI VFQ in populations with few functional deficits.<\/jats:p>","DOI":"10.1038\/s41598-025-21210-3","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T19:19:51Z","timestamp":1758914391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations between patient-reported vision impairment in low luminance and vision-related quality of life in intermediate age-related macular degeneration"],"prefix":"10.1038","volume":"15","author":[{"given":"Jan Henrik","family":"Terheyden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Gittel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn H.","family":"Guymer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Finger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"21210_CR1","doi-asserted-by":"publisher","first-page":"1138428","DOI":"10.3389\/fpubh.2023.1138428","volume":"11","author":"B Jiang","year":"2023","unstructured":"Jiang, B., Jiang, C., Li, J. & Lu, P. Trends and disparities in disease burden of age-related macular degeneration from 1990 to 2019: Results from the global burden of disease study 2019. Front. Public Health. 11, 1138428 (2023).","journal-title":"Front. public. Health"},{"key":"21210_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ophtha.2007.03.008","volume":"115","author":"TY Wong","year":"2008","unstructured":"Wong, T. Y. et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115, 116\u2013126 (2008).","journal-title":"Ophthalmology"},{"key":"21210_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ophtha.2015.09.036","volume":"123","author":"S Schmitz-Valckenberg","year":"2016","unstructured":"Schmitz-Valckenberg, S. et al. Natural history of geographic atrophy progression secondary to Age-Related macular degeneration (Geographic atrophy progression Study). Ophthalmology 123, 361\u2013368 (2016).","journal-title":"Ophthalmology"},{"key":"21210_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-320848","author":"JH Terheyden","year":"2022","unstructured":"Terheyden, J. H. et al. Disease-specific assessment of vision impairment in low luminance in age-related macular degeneration - A MACUSTAR study report. Br. J. Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-320848 (2022).","journal-title":"Br. J. Ophthalmol."},{"key":"21210_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1477-7525-4-97","volume":"4","author":"J Mitchell","year":"2006","unstructured":"Mitchell, J. & Bradley, C. Quality of life in age-related macular degeneration: A review of the literature. Health Qual. Life Outcomes. 4, 97 (2006).","journal-title":"Health Qual. Life Outcomes"},{"key":"21210_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.survophthal.2005.02.007","volume":"50","author":"JS Slakter","year":"2005","unstructured":"Slakter, J. S. & Stur, M. Quality of life in patients with age-related macular degeneration: Impact of the condition and benefits of treatment. Surv. Ophthalmol. 50, 263\u2013273 (2005).","journal-title":"Surv. Ophthalmol."},{"key":"21210_CR7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/hex.13254","volume":"24","author":"K Churruca","year":"2021","unstructured":"Churruca, K. et al. Patient-reported outcome measures (PROMs): A review of generic and condition-specific measures and a discussion of trends and issues. Health Expect. Int. J. public. Particip. Health Care Health Policy. 24, 1015\u20131024 (2021).","journal-title":"Health Expectations: Int. J. public. Participation Health Care Health Policy"},{"key":"21210_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1136\/bjophthalmol-2014-306544","volume":"99","author":"AK Krezel","year":"2015","unstructured":"Krezel, A. K., Hogg, R. E. & Azuara-Blanco, A. Patient-reported outcomes in randomised controlled trials on age-related macular degeneration. Br. J. Ophthalmol. 99, 1560\u20131564 (2015).","journal-title":"Br. J. Ophthalmol."},{"key":"21210_CR9","doi-asserted-by":"crossref","unstructured":"Mangione, C. M. et al. Identifying the content area for the 51-item national eye institute visual function questionnaire: results from focus groups with visually impaired persons. Arch. Ophthalmol. (Chicago, Ill.) 116, 227\u2013233 (1998, 1960).","DOI":"10.1001\/archopht.116.2.227"},{"key":"21210_CR10","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","volume":"116","author":"CM Mangione","year":"1998","unstructured":"Mangione, C. M. et al. Psychometric properties of the National eye Institute visual function questionnaire (NEI-VFQ). NEI-VFQ field test investigators. Arch. Ophthalmol. (Chicago Ill.: 1960). 116, 1496\u20131504 (1998).","journal-title":"Archives Ophthalmol. (Chicago Ill.: 1960)"},{"key":"21210_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.10.1.5","volume":"10","author":"SG Pondorfer","year":"2021","unstructured":"Pondorfer, S. G. et al. Development of the vision impairment in low luminance questionnaire. Transl. Vis. Sci. Technol. 10, 5 (2021).","journal-title":"Translational Vis. Sci. Technol."},{"key":"21210_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/tvst.11.4.21","volume":"11","author":"JH Terheyden","year":"2022","unstructured":"Terheyden, J. H. et al. Interviewer administration corresponds to self-administration of the vision impairment in low luminance (VILL) questionnaire. Transl. Vis. Sci. Technol. 11, 21 (2022).","journal-title":"Translational Vis. Sci. Technol."},{"key":"21210_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12877-023-04317-y","volume":"23","author":"JH Terheyden","year":"2023","unstructured":"Terheyden, J. H. et al. Patient-reported vision impairment in low luminance predicts multiple falls. BMC Geriatr. 23, 583 (2023).","journal-title":"BMC Geriatr."},{"key":"21210_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/tvst.11.5.10","volume":"11","author":"JE Goldstein","year":"2022","unstructured":"Goldstein, J. E. et al. The NEI VFQ-25C: Calibrating items in the national eye institute visual function questionnaire-25 to enable comparison of outcome measures. Transl. Vis. Sci. Technol. 11, 10 (2022).","journal-title":"Translational Vis. Sci. Technol."},{"key":"21210_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.8.5.3","volume":"8","author":"MB McGuinness","year":"2019","unstructured":"McGuinness, M. B. et al. Properties of the impact of vision impairment and night vision questionnaires among people with intermediate age-related macular degeneration. Transl. Vis. Sci. Technol. 8, 3 (2019).","journal-title":"Translational Vis. Sci. Technol."},{"key":"21210_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/OPX.0b013e318141fe75","volume":"84","author":"K Pesudovs","year":"2007","unstructured":"Pesudovs, K., Burr, J. M., Harley, C. & Elliott, D. B. The development, assessment, and selection of questionnaires. Optometry Vis. Sci. Offi. Publi. Am. Acad. Optometry. 84, 663\u2013674 (2007).","journal-title":"Optometry Vis. Science: Official Publication Am. Acad. Optometry"},{"key":"21210_CR17","doi-asserted-by":"crossref","unstructured":"Boone, W. J., Staver, J. R. & Yale, M. S. Rasch Analysis in the Human Sciences (Springer, 2014).","DOI":"10.1007\/978-94-007-6857-4"},{"key":"21210_CR18","unstructured":"Linacre, J. M. WINSTEPS rasch measurement computer program user\u2019s guide. Available at www.winsteps.com."},{"key":"21210_CR19","unstructured":"Food and Drug Administration. Patient-reported outcome measures: Use in medical product development to support labeling claims. Guidance Ind (2009)."},{"key":"21210_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000491402","volume":"241","author":"RP Finger","year":"2019","unstructured":"Finger, R. P. et al. Development and clinical validation of Functional, Structural, and Patient-Reported endpoints in intermediate age-related macular degeneration. Ophthalmol. J. Int. D\u2019ophtalmol. Int. J. Ophthalmol. Z. Fur Augenheilkunde. 241, 61\u201372 (2019).","journal-title":"Ophthalmol. J. Int. D\u2019ophtalmologie Int. J. Ophthalmol. Z. Fur Augenheilkunde"},{"key":"21210_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s13063-020-04595-6","volume":"21","author":"JH Terheyden","year":"2020","unstructured":"Terheyden, J. H. et al. Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR. Trials 21, 659 (2020).","journal-title":"Trials"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21210-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21210-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21210-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T19:19:52Z","timestamp":1758914392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21210-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21210"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21210-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"33317"}}